Guo Long

794 total citations
26 papers, 492 citations indexed

About

Guo Long is a scholar working on Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Guo Long has authored 26 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cancer Research, 11 papers in Molecular Biology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Guo Long's work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Cancer Genomics and Diagnostics (6 papers) and Cancer, Lipids, and Metabolism (5 papers). Guo Long is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Cancer Genomics and Diagnostics (6 papers) and Cancer, Lipids, and Metabolism (5 papers). Guo Long collaborates with scholars based in China, United States and Saudi Arabia. Guo Long's co-authors include Ledu Zhou, Jianing Tang, Xiao Liang, Xi Hu, Dong Wang, Zhiming Wang, Liang Xiao, Lei Yao, Kuan Hu and Yongguang Tao and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Guo Long

25 papers receiving 489 citations

Peers

Countries citing papers authored by Guo Long

Since Specialization

Citations

This map shows the geographic impact of Guo Long's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guo Long with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guo Long more than expected).

Fields of papers citing papers by Guo Long

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guo Long. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guo Long. The network helps show where Guo Long may publish in the future.

Co-authorship network of co-authors of Guo Long

This figure shows the co-authorship network connecting the top 25 collaborators of Guo Long. A scholar is included among the top collaborators of Guo Long based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guo Long. Guo Long is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Deubiquitylating Enzymes in Hepatocellular Carcinoma 2025 ·International Journal of Biological Sciences ·(unknown), (unknown), Guo Long, Yilin Pan, Yulin Xie, (unknown), Xiao Liang, Jianing Tang, Ledu Zhou	0
2	Targeting USP8 Inhibits O‐GlcNAcylation of SLC7A11 to Promote Ferroptosis of Hepatocellular Carcinoma via Stabilization of OGT 2023 ·Advanced Science ·Jianing Tang, Guo Long, Kuan Hu, Desheng Xiao, Shuang Liu, Xiao Liang, Ledu Zhou, Yongguang Tao	65
3	UCHL3 inhibits ferroptosis by stabilizing β-catenin and maintains stem-like properties of hepatocellular carcinoma cells 2023 ·Free Radical Biology and Medicine ·Guo Long, (unknown), Dong Wang, (unknown), Kuan Hu, Ledu Zhou, Jianing Tang	13
4	ATR‐dependent ubiquitin‐specific protease 20 phosphorylation confers oxaliplatin and ferroptosis resistance 2023 ·SHILAP Revista de lepidopterología ·Jianing Tang, Guo Long, Desheng Xiao, Shuang Liu, Xiao Liang, Ledu Zhou, Yongguang Tao	16
5	USP8 positively regulates hepatocellular carcinoma tumorigenesis and confers ferroptosis resistance through β-catenin stabilization 2023 ·Cell Death and Disease ·Jianing Tang, Guo Long, Xiao Liang, Ledu Zhou	53
6	Development of tryptophan metabolism patterns to predict prognosis and immunotherapeutic responses in hepatocellular carcinoma 2023 ·Aging ·Guo Long, Dong Wang, Jianing Tang, Weifeng Tang	5
7	The deubiquitinase EIF3H promotes hepatocellular carcinoma progression by stabilizing OGT and inhibiting ferroptosis 2023 ·Cell Communication and Signaling ·Jianing Tang, Guo Long, (unknown), Ledu Zhou, Yangying Zhou, (unknown)	16
8	Spectrum of BRCA1 interacting helicase 1 aberrations and potential prognostic and therapeutic implication: a pan cancer analysis 2023 ·Scientific Reports ·Guo Long, Kuan Hu, Xiaofang Zhang, Ledu Zhou, Juanni Li	2
9	Identification of different proteins binding to Na, K-ATPase α1 in LPS-induced ARDS cell model by proteomic analysis 2022 ·Proteome Science ·(unknown), Guo Long, (unknown), (unknown), (unknown), (unknown)	3
10	Drug Resistance and Risk Factors for Acquisition of Gram-Negative Bacteria and Carbapenem-Resistant Organisms Among Liver Transplant Recipients 2022 ·Infectious Diseases and Therapy ·(unknown), Guo Long, (unknown), Qiquan Wan	8
11	Identification and validation of a tyrosine metabolism-related prognostic prediction model and characterization of the tumor microenvironment infiltration in hepatocellular carcinoma 2022 ·Frontiers in Immunology ·Yangying Zhou, Xuanxuan Li, Guo Long, (unknown), Ledu Zhou, Jianing Tang	24
12	Identification of senescence-related subtypes, establishment of a prognosis model, and characterization of a tumor microenvironment infiltration in breast cancer 2022 ·Frontiers in Immunology ·Yanling Zhou, Liang Xiao, Guo Long, Jing Cao, Shuang Liu, (unknown), Ledu Zhou, Jianing Tang	11
13	Splenic Volume, an Easy-To-Use Predictor of HCC Late Recurrence for HCC Patients After Hepatectomy 2022 ·Frontiers in Oncology ·(unknown), Guo Long, (unknown), (unknown), (unknown), Ledu Zhou	5
14	Insulin alleviates LPS-induced ARDS via inhibiting CUL4B-mediated proteasomal degradation and restoring expression level of Na,K-ATPase α1 subunit through elevating HCF-1 2022 ·Biochemical and Biophysical Research Communications ·(unknown), Zhengyuan Yu, Guo Long, (unknown), (unknown)	2
15	MINDY1 promotes breast cancer cell proliferation by stabilizing estrogen receptor α 2021 ·Cell Death and Disease ·Jianing Tang, Yongwen Luo, Guo Long, Ledu Zhou	23
16	A Nomogram Based on Preoperative Inflammatory Indices and ICG-R15 for Prediction of Liver Failure After Hepatectomy in HCC Patients 2021 ·Frontiers in Oncology ·(unknown), Guo Long, Dong Wang, Xudong Liu, Xiao Liang, (unknown), (unknown), (unknown), Ledu Zhou, (unknown), (unknown)	10
17	Prognostic Nutritional Index and Systemic Immune-Inflammation Index Predict the Prognosis of Patients with HCC 2020 ·Journal of Gastrointestinal Surgery ·Dong Wang, Xi Hu, Liang Xiao, Guo Long, Lei Yao, Zhiming Wang, Ledu Zhou	134
18	A-G Score Associated With Outcomes in Solitary Hepatocellular Carcinoma Patients After Hepatectomy 2020 ·Frontiers in Oncology ·Guo Long, Junyi Shen, Ledu Zhou	6
19	The clinical value of total plasma cell-free DNA in hepatitis B virus-related hepatocellular carcinoma 2019 ·Annals of Translational Medicine ·(unknown), Xi Hu, Guo Long, Xiao Liang, Zhiming Wang, Ledu Zhou	17
20	Single-arm, multi-centre phase II study of lobaplatin combined with docetaxel for recurrent and metastatic nasopharyngeal carcinoma patients 2014 ·Oral Oncology ·Guo Long, Jing Lin, (unknown), (unknown), Xianglin Yuan, Guang Hu, Qi Mei, (unknown), (unknown)	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact